Učitavanje...
Isoagglutinin Reduction in Human Immunoglobulin Products by Donor Screening
INTRODUCTION: Hemolysis is considered a class effect and a rare adverse event that can occur following therapy with human normal immunoglobulin for intravenous administration [i.e., intravenous immunoglobulin (IVIG)]. Anti-A/B isoagglutinins (also referred to as isohemagglutinins) originating from d...
Spremljeno u:
| Izdano u: | Biol Ther |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Healthcare
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4254866/ https://ncbi.nlm.nih.gov/pubmed/24841428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13554-014-0016-2 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|